BPC-157 and TB-500 are the two names that come up most in conversations about “healing peptides,” often together as the so-called Wolverine stack. The hype online runs far ahead of the science. This guide compares them side by side and is honest about what is known, what is guessed, and what nobody has tested yet.
Key takeaways
- BPC-157 is a 15-amino-acid synthetic peptide based on a protein found in human gastric juice.
- TB-500 is a synthetic peptide based on thymosin beta-4, a protein involved in cell movement and repair.
- Almost all of the evidence for both comes from animal and cell studies.
- Neither is FDA-approved, neither has an established human dose, and both are banned by WADA.
BPC-157 vs TB-500 at a glance
| BPC-157 | TB-500 | |
|---|---|---|
| Full name | Body Protection Compound-157 | Synthetic thymosin beta-4 fragment/analog |
| Size | 15 amino acids | Varies by seller; based on the active region of a 43-amino-acid protein |
| Origin | Derived from a protein in human gastric juice | Based on thymosin beta-4, found in nearly all human cells |
| Main research areas | Gut lining, tendon, ligament, muscle and blood vessel repair | Cell migration, wound healing, heart and eye tissue repair |
| Human evidence | A few very small pilot reports, no large controlled trials | None for TB-500 itself; the parent protein has had some human trials |
| FDA status | Not approved | Not approved |
| WADA status | Prohibited (S0, named specifically) | Prohibited (S2, thymosin beta-4 and derivatives) |
What is BPC-157?
BPC-157 was developed and studied mainly by a research group at the University of Zagreb in Croatia. It’s a synthetic sequence taken from a larger protein found in gastric juice. One reason it gets attention is that it appears unusually stable in stomach acid for a peptide, which is why both oral and injected forms have been studied in animals.
Proposed mechanisms
Animal and cell studies suggest BPC-157 may:
- Encourage angiogenesis (new blood vessel growth), which helps bring nutrients to healing tissue
- Interact with the nitric oxide system, which affects blood flow
- Influence growth-factor signaling involved in tendon and ligament repair
- Protect the lining of the stomach and intestines in rodent injury models
What the research shows
Hundreds of rodent studies report faster healing of tendons, ligaments, muscle, bone and gut injuries. That sounds impressive, but there are big caveats: much of the work comes from one research group, the doses are given per kilogram of rat, and rodent healing results frequently don’t carry over to people. Human data is limited to a couple of very small pilot reports without control groups.
What is TB-500?
Thymosin beta-4 (Tβ4) is a natural 43-amino-acid protein that binds actin, a structural protein cells use to move and change shape. Because repair cells need to migrate into damaged tissue, Tβ4 became a research target for wound healing.
“TB-500” is a name used in the research market for synthetic peptides based on the active region of Tβ4. What’s actually in a TB-500 vial can differ from seller to seller, which is one more reason to check a certificate of analysis.
What the research shows
Animal studies of Tβ4 report benefits in skin wounds, heart tissue after injury, and the cornea. The full-length protein has been tested in human clinical trials as an eye drop for dry eye and corneal conditions, with mixed results. None of that is the same as injecting a research-market TB-500 product, and no human dose for TB-500 exists.
Why people combine them
The theory behind the combination is that they act on different parts of the healing process: BPC-157 on blood supply and growth-factor signaling, TB-500 on cell movement. That’s a reasonable hypothesis, but it is only a hypothesis. We found no controlled studies testing the two together, in animals or people.
Safety: what we don’t know
- No long-term human safety data exists for either compound.
- Growth signals cut both ways. Anything that promotes blood vessel growth and cell migration raises theoretical questions about existing tumors. This hasn’t been proven, but it hasn’t been ruled out either.
- Product quality varies. Research-market products aren’t made under drug manufacturing rules. Contamination, wrong compounds and wrong amounts are real risks.
- Regulatory status. The FDA has flagged BPC-157 as a bulk substance with potential safety risks for compounding. Check the FDA’s current lists, as this area changes.
Dosing
Following Pep Guide’s policy: there is no established human dose for BPC-157 or TB-500, because neither has an FDA label or adequate human trials. Numbers you see online are extrapolated from animal studies or passed around in forums.
The bottom line
BPC-157 and TB-500 are interesting research compounds with a large body of animal work and almost no human evidence. They are not approved, not proven in people, and banned in tested sports. If you’re dealing with an injury, a sports medicine doctor or physical therapist has treatments with real human data behind them.
Related reading: Peptides and sports drug testing · How to spot a sketchy peptide vendor · Compound Library
Frequently asked questions
Which is better, BPC-157 or TB-500?
Neither has been proven in controlled human trials, so there’s no evidence-based answer. In animal research, BPC-157 is studied more for gut and tendon healing and TB-500 for wound healing and cell migration.
Is BPC-157 FDA-approved?
No. BPC-157 is not approved by the FDA for any use, and it is not permitted as a bulk ingredient for standard compounding.
Is TB-500 the same as thymosin beta-4?
Not exactly. Thymosin beta-4 is a natural 43-amino-acid protein. TB-500 is a name for synthetic peptides based on its active region, and the exact product varies by seller.
Are BPC-157 and TB-500 banned in sports?
Yes. Both are on the WADA Prohibited List. BPC-157 falls under non-approved substances (S0) and thymosin beta-4 and its derivatives under S2.
Medical disclaimer: Pep Guide is for educational purposes only. It is not medical advice, diagnosis or treatment. Research changes over time. Talk to a licensed healthcare provider before starting, stopping or changing any medication or compound.